Intravenous high-dose interferon with or without maintenance treatment in melanoma at high risk of recurrence: meta-analysis of three trials.
Malczewski A. et al, (2016), Cancer Med, 5, 17 - 23
SOCQER-2 Study: Preliminary analysis of multicentre recruitment after surgery in advanced ovarian cancer
Kumar S. et al, (2016), INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 26, 832 - 833
Turning the concept of synthetic lethality on its head
Parkes EE. and Kennedy RD., (2016), TRANSLATIONAL CANCER RESEARCH, 5, S1145 - S1148
Window of opportunity studies: investigating the bioactivity of metformin in cancer
Lipplaa A. et al, (2015), Journal of Endocrinology, Diabetes and Obesity
A Potential Novel Application of Eltrombopag: A Combination Agent to Enhance Iron Chelation Therapy
Koumoutsea EV. et al, (2015), BLOOD, 126
Ezh2 and Runx1 Mutations Targeted to Early Lymphoid Progenitors Collaborate to Promote Early Thymic Progenitor Leukemia
Booth C. et al, (2015), BLOOD, 126
Single Cell Whole Transcriptome Analysis Reveals Distinct Molecular Signatures of Therapy-Resistant Chronic Myeloid Leukemia Stem Cells
Giustacchini A. et al, (2015), BLOOD, 126
Dose-Finding Quantitative 18F-FDG PET Imaging Study with the Oral Pan-AKT Inhibitor GSK2141795 in Patients with Gynecologic Malignancies.
Gungor H. et al, (2015), J Nucl Med, 56, 1828 - 1835
Diagnosis and treatment of Merkel Cell Carcinoma. European consensus-based interdisciplinary guideline.
Lebbe C. et al, (2015), Eur J Cancer, 51, 2396 - 2403
ONGOING HIGH QUALITY RANDOMISED TRIALS ARE HELPING DEFINE THE ROLE OF RADIOTHERAPY IN MELANOMA
Fogarty G. et al, (2015), Asia-Pacific Journal of Clinical Oncology, 11, 73 - 74
Pragmatic staging of oesophageal cancer using decision theory involving selective endoscopic ultrasonography, PET and laparoscopy.
Findlay JM. et al, (2015), Br J Surg, 102, 1488 - 1499
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer.
Bowtell DD. et al, (2015), Nat Rev Cancer, 15, 668 - 679
The La-Related Proteins, a Family with Connections to Cancer
Blagden None. and stavraka C., (2015), Biomolecules
Harnessing Pandemonium: The Clinical Implications of Tumor Heterogeneity in Ovarian Cancer.
Blagden None., (2015), Frontier in oncology
LARP1 post-transcriptionally regulates mTOR and contributes to cancer progression
Blagden None. et al, (2015), Oncogene
The next steps in improving the outcomes of advanced ovarian cancer.
Blagden None. et al, (2015), Womens' health
Application of single-cell genomics in cancer: promise and challenges.
Wills QF. and Mead AJ., (2015), Hum Mol Genet, 24, R74 - R84
IGF-1R inhibition induces schedule-dependent sensitization of human melanoma to temozolomide
Macaulay V. et al, (2015), Oncotarget